Additionally, gut microbiotacan influence the efficacy of radioactive iodine therapy by modulating theexpression of NIS, which facilitates iodine uptake in thyroid cancer cells; thus,microbiota-derived metabolites like SCFAs can enhance the sensitivity of tumor cellsto radioactive iodine, potentially improving treatment outcomes. This evidence concerns the gene SLC5A5 and neoplasm.